Jinbin Liu

Title: Jinbin Liu: Innovator in Bioengineering

Introduction

Jinbin Liu is a prominent inventor based in Wuxi, China. He has made significant contributions to the field of bioengineering, particularly through his innovative approaches to genetically engineered strains. With a total of 3 patents, Liu's work showcases his dedication to advancing biotechnological applications.

Latest Patents

Liu's latest patents include a genetically engineered strain that introduces L-amino acid oxidase genes, α-keto acid decarboxylase genes, alcohol dehydrogenase genes, and enzyme genes capable of reducing NAD(P) to NAD(P)H. This strain is designed for the biosynthesis of phenylethanoids, offering a method characterized by simple operation, low cost, and high synthesis efficiency. The industrialization prospects of this method are promising.

Another notable patent involves an engineering strain for the joint production of Danshensu and alanine. This invention constructs a three-enzyme co-expression genetic engineering strain, enhancing substrate transport and reducing product decomposition. The strain can produce optically pure D-danshensu and L-danshensu, along with pyruvic acid, while maintaining a simple production process with easily available raw materials.

Career Highlights

Jinbin Liu is affiliated with Jiangnan University, where he continues to engage in groundbreaking research. His work has not only contributed to academic knowledge but also holds potential for practical applications in the industry.

Collaborations

Liu collaborates with notable colleagues, including Yujie Cai and Tianzhen Xiong. Their combined expertise enhances the research and development efforts in bioengineering.

Conclusion

Jinbin Liu's innovative contributions to bioengineering through his patented inventions demonstrate his commitment to advancing the field. His work has the potential to significantly impact industrial applications and improve biotechnological processes.